Advanced Ultrasound in Pleural Infection (AUDIO)

May 15, 2017 updated by: University of Oxford

Pleural infection is a potentially serious infection of the fluid normally found around the lung and current evidence suggests its incidence is increasing in both adult and paediatric populations.

Identification of bacterial pathogens causing pleural infection is of paramount importance in the clinical care of patients are currently, only 40% of patients have a laboratory confirmed microbiological diagnosis for their pleural infection. An unclear diagnosis can be due to various reasons such as a small sample volume therefore the aim of the AUDIO study is to ascertain the capacity of pleural biopsies in improving the microbiological yield of pleural infection.

Currently, there are no well validated methods for identifying patients presenting with pleural infection on the basis of initial ultrasound imaging. The AUDIO study will define the role of baseline thoracic ultrasound in predicting the radiographic, clinical and surgical outcomes of patients with pleural infection.

The AUDIO study aims to recruit 50 patients from 2 centres with specific pleural expertise and these patients will be followed up over a 12 month period. Investigators hope that through the information gathered from ultrasound imaging and pleural biopsies, it will aid physicians' clinical and therapeutic decision making when treating patients with pleural infection.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bristol, United Kingdom, BS10 5NB
        • North Bristol NHS Trust, Southmead Hospital
      • Oxford, United Kingdom, OX3 7LE
        • Oxford Respiratory Trials Unit, Churchill Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • A clinical presentation compatible with pleural infection
  • A pleural fluid collection that may or (rarely according to clinical judgement) may not require drainage that meets at least one or more of the following criteria:
  • Purulent
  • Gram stain positive for bacteria
  • Bacterial culture positive
  • Acidic with a pH <7.2
  • Low pleural fluid glucose <3mmol/L (<55mg/dL)
  • CT evidence of pleural infection (consolidation of underlying lung with enhancing pleural collection on contrast-enhanced CT)

Exclusion Criteria:

  • Age <18 years
  • No pleural fluid available for analysis
  • Previous pneumonectomy on the side of pleural infection
  • Expected survival <3 months due to co-morbid disease
  • Inability to give informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
To increase microbiological yield.
Time Frame: Positive microbiological results on pleural biopsy at baseline compared with positive microbiological results on pleural fluid.
Positive microbiological results on pleural biopsy at baseline compared with positive microbiological results on pleural fluid.

Secondary Outcome Measures

Outcome Measure
Time Frame
Radiographic improvement in area of pleural collection measured by the percentage of the ipsilateral hemithorax occupied by effusion on chest radiography.
Time Frame: Day 1 and Day 7
Day 1 and Day 7
Mortality from pleural infection
Time Frame: 3 and 12 months
3 and 12 months
Duration of hospital (in patient) stay
Time Frame: From the date of initial hospital admission to the date of discharge assessed up to 2 weeks.
From the date of initial hospital admission to the date of discharge assessed up to 2 weeks.
Necessity for surgical fluid drainage documented in case report forms over study completion
Time Frame: 3 and 12 months
3 and 12 months
Pleural fluid drainage over 7 days
Time Frame: First 7 days of trial involvement
First 7 days of trial involvement

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2015

Primary Completion (Actual)

March 14, 2017

Study Completion (Actual)

March 14, 2017

Study Registration Dates

First Submitted

October 21, 2015

First Submitted That Met QC Criteria

November 16, 2015

First Posted (Estimate)

November 20, 2015

Study Record Updates

Last Update Posted (Actual)

May 16, 2017

Last Update Submitted That Met QC Criteria

May 15, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • AUDIO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pleural Infection

Clinical Trials on Pleural biopsy sampling

Subscribe